Skip to Content

Biologics, Volume 5, Issue 4

2025 December - 12 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (12)

  • Article
  • Open Access
753 Views
14 Pages

Automated Scale-Down Development and Optimization of [68Ga]Ga-DOTA-EMP-100 for Non-Invasive PET Imaging and Targeted Radioligand Therapy of c-MET Overactivation in Cancer

  • Silvia Migliari,
  • Anna Gagliardi,
  • Alessandra Guercio,
  • Maura Scarlattei,
  • Giorgio Baldari,
  • Alex Gibson,
  • Christophe Portal and
  • Livia Ruffini

17 December 2025

Background/Objectives: Overactivation of the HGF/c-MET pathway is implicated in various cancers, making its inhibition a promising therapeutic strategy. While several MET-targeting agents are currently approved or in advanced clinical development, pa...

  • Article
  • Open Access
1,698 Views
12 Pages

Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease

  • Mustafa Gandhi,
  • Harleen Kaur Chela,
  • Maxwell A. Barffour,
  • Emily Bosak,
  • Emily Reznicek,
  • Kevin Luton,
  • Matthew Bechtold and
  • Yezaz A. Ghouri

1 December 2025

Introduction: Patients with inflammatory bowel disease (IBD) have an increased risk of Clostridioides difficile infection (CDI). While antibiotic exposure has been considered the most prominent risk factor for CDI, proton pump inhibitor (PPI) use is...

  • Review
  • Open Access
1 Citations
1,528 Views
15 Pages

Mesenchymal Stem Cells and Their Derivatives: Old Problems and New Possibilities in Regenerative Medicine for Neurological Diseases

  • Elvira Akhmetzyanova,
  • Ilya Shulman,
  • Taisiya Fakhrutdinova,
  • Albert Rizvanov and
  • Yana Mukhamedshina

28 November 2025

Mesenchymal stem cells are multipotent stromal cells with immunomodulatory, anti-inflammatory, and trophic properties that support tissue repair and regeneration. Increasing evidence suggests that their therapeutic effects are primarily mediated by p...

  • Review
  • Open Access
2 Citations
2,601 Views
21 Pages

10 November 2025

Lyophilization (freeze-drying) has become a cornerstone pharmaceutical technology for stabilizing biopharmaceuticals, overcoming the inherent instability of biologics, vaccines, and complex drug formulations in aqueous environments. The appropriate l...

  • Article
  • Open Access
980 Views
20 Pages

3 November 2025

Background: Various thiolactones are known as biologically active compounds, capable of stimulating the development of several human diseases and quorum sensing of Gram–positive bacteria. The enzymatic hydrolysis of thiolactones represents a pr...

  • Article
  • Open Access
1 Citations
3,084 Views
11 Pages

22 October 2025

Background/Objectives: Omalizumab is a monoclonal anti-IgE antibody approved for the treatment of chronic urticaria. There are no established or validated prognostic markers currently available to identify likely responders. The aim of this study was...

  • Article
  • Open Access
1,371 Views
25 Pages

13 October 2025

Background/Objectives: Obesity increases reactive oxygen species (ROS), thereby triggering oxidative stress. Coriander seeds contain polyphenolic compounds that act as natural antioxidants to reduce oxidative stress. Coriander seed ethanolic extract...

  • Article
  • Open Access
2,400 Views
15 Pages

11 October 2025

Background/Objectives: Sera from patients before and after organ transplantation were tested at two different temperatures, 21 °C and 37 °C. Currently, organs are transported under normothermic conditions (37 °C). This observational pilot...

  • Case Report
  • Open Access
1,077 Views
7 Pages

Rituximab-Associated Myocardial Injury in a Young Woman with Granulomatosis with Polyangiitis: A Case Report

  • Natasha E. Barton,
  • Elizabeth A. Stein,
  • Kathryn Mulvaney and
  • Yevgeniya Scherbak

10 October 2025

Background: Rituximab is a monoclonal antibody targeting CD20, commonly used to treat autoimmune diseases such as granulomatosis with polyangiitis (GPA) and rheumatoid arthritis. While generally well-tolerated, serious adverse events, including infus...

  • Article
  • Open Access
2 Citations
1,338 Views
38 Pages

29 September 2025

Background and Objectives: Probiotics are live microorganisms that promote health when consumed in adequate amounts, ensure the balance of bacterial composition in the digestive system, and suppress harmful pathogenic bacteria, with overall implicati...

XFacebookLinkedIn
Biologics - ISSN 2673-8449